Experts have called for reforms of public hospitals and more legislation on the pharmaceutical industry, after police revealed more details on Tuesday of suspected financial violations by GlaxoSmithKline China.

The British pharmaceutical giant has been under investigation since early July over suspected bribery and tax-related violations, more details of which have been provided recently by company employees, according to the website of the Ministry of Public Security.

According to police investigators, the pharmaceutical company had "indulged" in the bribery of doctors - or at least "given tacit permission" - saying that individual employees were responsible for transgressions.